Loading…
The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line
The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor (PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive steroidogenic cells including the MA-10 Leydig...
Saved in:
Published in: | The Journal of biological chemistry 1994-09, Vol.269 (35), p.22105-22112 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713 |
---|---|
cites | cdi_FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713 |
container_end_page | 22112 |
container_issue | 35 |
container_start_page | 22105 |
container_title | The Journal of biological chemistry |
container_volume | 269 |
creator | M Garnier N Boujrad S O Ogwuegbu J R Hudson, Jr V Papadopoulos |
description | The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor
(PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive
steroidogenic cells including the MA-10 Leydig tumor cells. The present study was designed to characterize the role of DBI
and PBR in the R2C rat Leydig tumor constitutive steroid-producing cell model. Both DBI and PBR were present in R2C cells.
R2C cell treatment with a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to DBI, but not sense, resulted
in the reduction of DBI levels and a concomitant dramatic decrease of the amount of progesterone produced. These observations
strongly suggested that DBI was important in maintaining constitutive steroidogenesis in R2C cells. Radioligand binding assays
revealed the presence of a single class of PBR binding sites with an affinity 10 times higher (Kd approximately 0.5 nM) than
that displayed by the MA-10 PBR (Kd approximately 5 nM). Photolabeling of R2C and MA-10 cell mitochondria with the photoactivatable
PBR ligand [3H]1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methyl-propyl)-3- isoquinolinecarboxamide showed that the M(r) 18,000
PBR protein was specifically labeled. This indicates that the R2C cells express a PBR protein which has properties similar
to the MA-10 PBR. Chemical crosslinking studies of purified metabolically radiolabeled DBI to mitochondria provided direct
evidence that DBI specifically binds to the M(r) 18,000 PBR protein. Moreover, DBI and a PBR synthetic ligand were able to
increase steroid production in isolated R2C cell mitochondria which express the 5 nM affinity receptor. However, mitochondrial
PBR binding was increased by 6-fold upon addition of the post-mitochondrial fraction, suggesting that a cytosolic factor modulates
the binding properties of PBR in R2C cells and is responsible for the 0.5 nM affinity receptor seen in intact cells. In conclusion,
these data demonstrate that DBI plays a key role in maintaining R2C constitutive steroidogenesis by binding to the mitochondrial
higher affinity PBR which promotes a continuous supply of cholesterol to the inner mitochondrial side chain cleavage cytochrome
P450. |
doi_str_mv | 10.1016/s0021-9258(17)31762-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76678094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76678094</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713</originalsourceid><addsrcrecordid>eNo9UV2L1DAULaKs4-pPWMiDiD5U89E07aMM6wcMCLqCbyFpbqdX2rQmqTL73_xvps6weUgI59xzLucUxQ2jbxll9btIKWdly2Xzmqk3gqmal-JRsWO0EaWQ7MfjYvdAeVo8i_Enzadq2VVx1VDFhJC74u_dAGSZx9MCS0IHxKG5h8VMpUXv0B8J-gEtpjkQ4x0xZMDjAPnT9-gxnciUsW6YvQtoRrJAwCXjZixT1iQW_P181kQPJECXfbJWXGMy6Ek3-5gwrQl_A4kJwoxuPoKHiDFbk5TX-8r35AAnh0eS1ikPdzCOZMx6z4snvRkjvLi818X3D7d3-0_l4cvHz_v3h7Kr2iaVNWtNJyqZbwu2sdz2vJLCOc6rxvWK9pY3zppKUqVU25jesJo52bSGdX1O6rp4ddZdwvxrhZj0hHHbwniY16hVXauGtlUmyjOxC3OMAXq9BJxMOGlG9Vab_rZ1ordONFP6f21a5Lmbi8FqJ3APU5eeMv7yjG_p_8EA2mJOHSbN61YLqTlnVIp_fwmlnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76678094</pqid></control><display><type>article</type><title>The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line</title><source>ScienceDirect</source><creator>M Garnier ; N Boujrad ; S O Ogwuegbu ; J R Hudson, Jr ; V Papadopoulos</creator><creatorcontrib>M Garnier ; N Boujrad ; S O Ogwuegbu ; J R Hudson, Jr ; V Papadopoulos</creatorcontrib><description>The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor
(PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive
steroidogenic cells including the MA-10 Leydig tumor cells. The present study was designed to characterize the role of DBI
and PBR in the R2C rat Leydig tumor constitutive steroid-producing cell model. Both DBI and PBR were present in R2C cells.
R2C cell treatment with a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to DBI, but not sense, resulted
in the reduction of DBI levels and a concomitant dramatic decrease of the amount of progesterone produced. These observations
strongly suggested that DBI was important in maintaining constitutive steroidogenesis in R2C cells. Radioligand binding assays
revealed the presence of a single class of PBR binding sites with an affinity 10 times higher (Kd approximately 0.5 nM) than
that displayed by the MA-10 PBR (Kd approximately 5 nM). Photolabeling of R2C and MA-10 cell mitochondria with the photoactivatable
PBR ligand [3H]1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methyl-propyl)-3- isoquinolinecarboxamide showed that the M(r) 18,000
PBR protein was specifically labeled. This indicates that the R2C cells express a PBR protein which has properties similar
to the MA-10 PBR. Chemical crosslinking studies of purified metabolically radiolabeled DBI to mitochondria provided direct
evidence that DBI specifically binds to the M(r) 18,000 PBR protein. Moreover, DBI and a PBR synthetic ligand were able to
increase steroid production in isolated R2C cell mitochondria which express the 5 nM affinity receptor. However, mitochondrial
PBR binding was increased by 6-fold upon addition of the post-mitochondrial fraction, suggesting that a cytosolic factor modulates
the binding properties of PBR in R2C cells and is responsible for the 0.5 nM affinity receptor seen in intact cells. In conclusion,
these data demonstrate that DBI plays a key role in maintaining R2C constitutive steroidogenesis by binding to the mitochondrial
higher affinity PBR which promotes a continuous supply of cholesterol to the inner mitochondrial side chain cleavage cytochrome
P450.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1016/s0021-9258(17)31762-3</identifier><identifier>PMID: 8071335</identifier><language>eng</language><publisher>United States: American Society for Biochemistry and Molecular Biology</publisher><subject>Animals ; Base Sequence ; Carrier Proteins - physiology ; Diazepam Binding Inhibitor ; Humans ; Leydig Cell Tumor ; Leydig Cells - metabolism ; Male ; Mitochondria - metabolism ; Molecular Sequence Data ; Oligodeoxyribonucleotides ; Progesterone - biosynthesis ; Rats ; Receptors, GABA-A - physiology ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 1994-09, Vol.269 (35), p.22105-22112</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713</citedby><cites>FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8071335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>M Garnier</creatorcontrib><creatorcontrib>N Boujrad</creatorcontrib><creatorcontrib>S O Ogwuegbu</creatorcontrib><creatorcontrib>J R Hudson, Jr</creatorcontrib><creatorcontrib>V Papadopoulos</creatorcontrib><title>The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor
(PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive
steroidogenic cells including the MA-10 Leydig tumor cells. The present study was designed to characterize the role of DBI
and PBR in the R2C rat Leydig tumor constitutive steroid-producing cell model. Both DBI and PBR were present in R2C cells.
R2C cell treatment with a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to DBI, but not sense, resulted
in the reduction of DBI levels and a concomitant dramatic decrease of the amount of progesterone produced. These observations
strongly suggested that DBI was important in maintaining constitutive steroidogenesis in R2C cells. Radioligand binding assays
revealed the presence of a single class of PBR binding sites with an affinity 10 times higher (Kd approximately 0.5 nM) than
that displayed by the MA-10 PBR (Kd approximately 5 nM). Photolabeling of R2C and MA-10 cell mitochondria with the photoactivatable
PBR ligand [3H]1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methyl-propyl)-3- isoquinolinecarboxamide showed that the M(r) 18,000
PBR protein was specifically labeled. This indicates that the R2C cells express a PBR protein which has properties similar
to the MA-10 PBR. Chemical crosslinking studies of purified metabolically radiolabeled DBI to mitochondria provided direct
evidence that DBI specifically binds to the M(r) 18,000 PBR protein. Moreover, DBI and a PBR synthetic ligand were able to
increase steroid production in isolated R2C cell mitochondria which express the 5 nM affinity receptor. However, mitochondrial
PBR binding was increased by 6-fold upon addition of the post-mitochondrial fraction, suggesting that a cytosolic factor modulates
the binding properties of PBR in R2C cells and is responsible for the 0.5 nM affinity receptor seen in intact cells. In conclusion,
these data demonstrate that DBI plays a key role in maintaining R2C constitutive steroidogenesis by binding to the mitochondrial
higher affinity PBR which promotes a continuous supply of cholesterol to the inner mitochondrial side chain cleavage cytochrome
P450.</description><subject>Animals</subject><subject>Base Sequence</subject><subject>Carrier Proteins - physiology</subject><subject>Diazepam Binding Inhibitor</subject><subject>Humans</subject><subject>Leydig Cell Tumor</subject><subject>Leydig Cells - metabolism</subject><subject>Male</subject><subject>Mitochondria - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Oligodeoxyribonucleotides</subject><subject>Progesterone - biosynthesis</subject><subject>Rats</subject><subject>Receptors, GABA-A - physiology</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNo9UV2L1DAULaKs4-pPWMiDiD5U89E07aMM6wcMCLqCbyFpbqdX2rQmqTL73_xvps6weUgI59xzLucUxQ2jbxll9btIKWdly2Xzmqk3gqmal-JRsWO0EaWQ7MfjYvdAeVo8i_Enzadq2VVx1VDFhJC74u_dAGSZx9MCS0IHxKG5h8VMpUXv0B8J-gEtpjkQ4x0xZMDjAPnT9-gxnciUsW6YvQtoRrJAwCXjZixT1iQW_P181kQPJECXfbJWXGMy6Ek3-5gwrQl_A4kJwoxuPoKHiDFbk5TX-8r35AAnh0eS1ikPdzCOZMx6z4snvRkjvLi818X3D7d3-0_l4cvHz_v3h7Kr2iaVNWtNJyqZbwu2sdz2vJLCOc6rxvWK9pY3zppKUqVU25jesJo52bSGdX1O6rp4ddZdwvxrhZj0hHHbwniY16hVXauGtlUmyjOxC3OMAXq9BJxMOGlG9Vab_rZ1ordONFP6f21a5Lmbi8FqJ3APU5eeMv7yjG_p_8EA2mJOHSbN61YLqTlnVIp_fwmlnw</recordid><startdate>19940902</startdate><enddate>19940902</enddate><creator>M Garnier</creator><creator>N Boujrad</creator><creator>S O Ogwuegbu</creator><creator>J R Hudson, Jr</creator><creator>V Papadopoulos</creator><general>American Society for Biochemistry and Molecular Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940902</creationdate><title>The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line</title><author>M Garnier ; N Boujrad ; S O Ogwuegbu ; J R Hudson, Jr ; V Papadopoulos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animals</topic><topic>Base Sequence</topic><topic>Carrier Proteins - physiology</topic><topic>Diazepam Binding Inhibitor</topic><topic>Humans</topic><topic>Leydig Cell Tumor</topic><topic>Leydig Cells - metabolism</topic><topic>Male</topic><topic>Mitochondria - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Oligodeoxyribonucleotides</topic><topic>Progesterone - biosynthesis</topic><topic>Rats</topic><topic>Receptors, GABA-A - physiology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>M Garnier</creatorcontrib><creatorcontrib>N Boujrad</creatorcontrib><creatorcontrib>S O Ogwuegbu</creatorcontrib><creatorcontrib>J R Hudson, Jr</creatorcontrib><creatorcontrib>V Papadopoulos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>M Garnier</au><au>N Boujrad</au><au>S O Ogwuegbu</au><au>J R Hudson, Jr</au><au>V Papadopoulos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1994-09-02</date><risdate>1994</risdate><volume>269</volume><issue>35</issue><spage>22105</spage><epage>22112</epage><pages>22105-22112</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor
(PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive
steroidogenic cells including the MA-10 Leydig tumor cells. The present study was designed to characterize the role of DBI
and PBR in the R2C rat Leydig tumor constitutive steroid-producing cell model. Both DBI and PBR were present in R2C cells.
R2C cell treatment with a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to DBI, but not sense, resulted
in the reduction of DBI levels and a concomitant dramatic decrease of the amount of progesterone produced. These observations
strongly suggested that DBI was important in maintaining constitutive steroidogenesis in R2C cells. Radioligand binding assays
revealed the presence of a single class of PBR binding sites with an affinity 10 times higher (Kd approximately 0.5 nM) than
that displayed by the MA-10 PBR (Kd approximately 5 nM). Photolabeling of R2C and MA-10 cell mitochondria with the photoactivatable
PBR ligand [3H]1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methyl-propyl)-3- isoquinolinecarboxamide showed that the M(r) 18,000
PBR protein was specifically labeled. This indicates that the R2C cells express a PBR protein which has properties similar
to the MA-10 PBR. Chemical crosslinking studies of purified metabolically radiolabeled DBI to mitochondria provided direct
evidence that DBI specifically binds to the M(r) 18,000 PBR protein. Moreover, DBI and a PBR synthetic ligand were able to
increase steroid production in isolated R2C cell mitochondria which express the 5 nM affinity receptor. However, mitochondrial
PBR binding was increased by 6-fold upon addition of the post-mitochondrial fraction, suggesting that a cytosolic factor modulates
the binding properties of PBR in R2C cells and is responsible for the 0.5 nM affinity receptor seen in intact cells. In conclusion,
these data demonstrate that DBI plays a key role in maintaining R2C constitutive steroidogenesis by binding to the mitochondrial
higher affinity PBR which promotes a continuous supply of cholesterol to the inner mitochondrial side chain cleavage cytochrome
P450.</abstract><cop>United States</cop><pub>American Society for Biochemistry and Molecular Biology</pub><pmid>8071335</pmid><doi>10.1016/s0021-9258(17)31762-3</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 1994-09, Vol.269 (35), p.22105-22112 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_proquest_miscellaneous_76678094 |
source | ScienceDirect |
subjects | Animals Base Sequence Carrier Proteins - physiology Diazepam Binding Inhibitor Humans Leydig Cell Tumor Leydig Cells - metabolism Male Mitochondria - metabolism Molecular Sequence Data Oligodeoxyribonucleotides Progesterone - biosynthesis Rats Receptors, GABA-A - physiology Tumor Cells, Cultured |
title | The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20polypeptide%20diazepam-binding%20inhibitor%20and%20a%20higher%20affinity%20mitochondrial%20peripheral-type%20benzodiazepine%20receptor%20sustain%20constitutive%20steroidogenesis%20in%20the%20R2C%20Leydig%20tumor%20cell%20line&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=M%20Garnier&rft.date=1994-09-02&rft.volume=269&rft.issue=35&rft.spage=22105&rft.epage=22112&rft.pages=22105-22112&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1016/s0021-9258(17)31762-3&rft_dat=%3Cproquest_cross%3E76678094%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c498t-619ac3459acbeb8b2bf2453dd2248df70fb28dba45077798afa161d589a1cf713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76678094&rft_id=info:pmid/8071335&rfr_iscdi=true |